Three stocks to watch as a big annual biotech conference gets underway

CNBC2021-05-31

The annual ASCO meeting begins at the end of the week, a conference that has often provided a tailwind for biotech and pharma names. Biotech has been a laggard this year, gaining big in February and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Tigger777
2021-06-01
Tigger777
Diversify the investment in BioNTech stocks
hmmwvms
2021-06-01
hmmwvms
L&C (like and comment) please. Thank you :)
- HH浩:
  Reciprocate
- hmmwvms:
  Thank you
Fartyclown
2021-06-01
Fartyclown
?
- Fartyclown:
  .
- Fartyclown:
  ??
- Godskitchen:
  skill
ryanlow
2021-06-01
ryanlow
wow
- aesemera:
  cheers!
- Shadotaiger:
  reply?
LiuQY
2021-06-01
LiuQY
Gooooooooo
- Singman:
  pls like and comment on me too.
- ryanlow:
  wow
MrMrsBean
2021-06-01
MrMrsBean
[強]
- WeiChyi:
  K

Leave a comment

147

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1104481164?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-05-31 21:48","share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","id":"1104481164","market":"us","top_or_hot":-1,"title":"Three stocks to watch as a big annual biotech conference gets underway","media":"CNBC","content":"<div>\n<p>The annual ASCO meeting begins at the end of the week, a conference that has often provided a tailwind for biotech and pharma names.\nBiotech has been a laggard this year, gaining big in February and ...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/31/3-stocks-to-watch-as-asco-conference-gets-underway-.html\">Source Link</a>\n\n</div>\n","source":"cnbc_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Three stocks to watch as a big annual biotech conference gets underway</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThree stocks to watch as a big annual biotech conference gets underway\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-31 21:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/05/31/3-stocks-to-watch-as-asco-conference-gets-underway-.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The annual ASCO meeting begins at the end of the week, a conference that has often provided a tailwind for biotech and pharma names.\nBiotech has been a laggard this year, gaining big in February and ...</p>\n\n<a href=\"https://www.cnbc.com/2021/05/31/3-stocks-to-watch-as-asco-conference-gets-underway-.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REGN","symbol_name":"再生元制药公司","start_time":0,"source_url":"https://www.cnbc.com/2021/05/31/3-stocks-to-watch-as-asco-conference-gets-underway-.html","article_id":"1104481164","we_media_id":null,"thumbnails":[],"rights":{"source":"cnbc_highlight","url":"https://www.cnbc.com/2021/05/31/3-stocks-to-watch-as-asco-conference-gets-underway-.html","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.ArticleHeader-headline{#titleStyle#}a{#lv2TextColor#}.ArticleHeader-time, .Author-authorNameAndSocial a{#sourceStyle#;}","selectors":".PageBuilder-pageWrapper","filters":".ArticleHeader-eyebrow, .RelatedTags-relatedTags","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1104481164","pubTimestamp":1622468928,"sourceInfo":{"source_id":"cnbc_highlight","name":"CNBC"},"weMediaInfo":null,"summary":"The annual ASCO meeting begins at the end of the week, a conference that has often provided a tailwi","collect":0,"end_time":0,"defaultTopTitle":"cnbc.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"REGN":"再生元制药公司","GILD":"吉利德科学","HOOK":"Hookipa Pharma Inc","ABBV":"艾伯维公司","LLY":"礼来","MRK":"默沙东"},"translate_title":"大型生物科技年会召开之际，三只股票值得关注","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABBV":0.9,"GILD":0.9,"HOOK":0.9,"LLY":0.9,"MRK":0.9,"REGN":0.9},"content_text":"The annual ASCO meeting begins at the end of the week, a conference that has often provided a tailwind for biotech and pharma names.\nBiotech has been a laggard this year, gaining big in February and March but declining and trading in a choppy range since then.\nBank of America analyst Geoff Meacham identified three companies that could get a positive reception at the meeting.\nThe The American Society of Clinical Oncology meeting will be virtual for a second year, and runs from from June 4 to June 8. Meacham said it is important but ASCO may not provide the pop to stocks it did in other years.\n“ASCO was by far and away the biggest medical conference of the year, and people looked forward to that. And you would have company presentations in front of 30,000 oncologists,” he said. “There would be hundreds of Wall Streeters. You could get a very good handle on what was the buzz of the meeting. SInce it’s virtual, it doesn’t have as much of its charm.”\nBut Meacham said ASCO could still be positive. “You have data that’s brand new and that could lead to approvals and some very good products,” he said.\nMeacham said he’s still positive on biotech despite its lackluster performance. He especially likes mid-cap biotech.\n“We’ve been pretty positive on the group. Recognizing that drug pricing has been a little bit of a cloud over the past couple of years, and 2021 is no different,” said Meacham. “But when you look at the pipeline, the midcap biotech pipeline looks fantastic.”\nThe pipeline in big pharma is got but not as robust. “For the most part, it’s singles and doubles. But not surprisingly, midcap biotech has some home run potential but with more risk. That’s what drives the industry - the innovation and new therapies - and that’s why we’re still positive.”\n\nThe IBB iShares NASDAQ Biotech ETF gained 0.4% last week, but it is up just 0.3% year-to-date. The widely followed IBB was down 1.7% for the month of May.\nMeacham identified three companies that could get a positive reception at the ASCO meeting. Bank of America has a buy rating on all of them. One of those is big pharma Bristol-Myers Squibb.\n“Bristol is probably one of the winners,” he said. The company’s anti-LAG-3 antibody relatlimab melanoma treatment has been in development and there will be data from a large phase 3 trial. He said the product was used with its Opdivo, and could have a better safety profile than the current treatment of Opdivo combined with Yervoy. He does expect Opdivo and Yervoy to maintain the lead share of the market going forward.\nBig cap biotech Amgen is presenting on its lung cancer drug Lumakras, which received Food and Drug Administration approval Friday. The drug was approved to treat lung cancer patients with a genetic mutation known as KRAS. The approval came sooner than expected and sent Amgen shares up more than 1.1% Friday.\nHe said it could be combined with other therapy, like Opdivo. “That two drug combination could be really profound,” he said.\nBiotech company Seagen is going to present on its Padcev treatment for bladder and kidney cancer, launched last year. “This is an update of existing data,” he said. The data shows patients live longer.\nThe study is a small phase 2 trial, but there is another larger phase 3 trial that combines the therapy with Merck’s Keytruda.\nOther companies with data to be presented at ASCO include Eli Lilly,Merck,Regeneron,Hookipa,AbbVie, and Gilead.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":119397959,"gmtCreate":1622517886371,"gmtModify":1704185496918,"author":{"id":"3583019971396816","authorId":"3583019971396816","name":"Tigger777","avatar":"https://static.tigerbbs.com/53969c426622bc828bc9dda9aa263652","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3583019971396816","idStr":"3583019971396816"},"htmlText":"Diversify the investment in&nbsp;BioNTech stocks&nbsp;","listText":"Diversify the investment in&nbsp;BioNTech stocks&nbsp;","text":"Diversify the investment in BioNTech stocks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/119397959","repostId":1104481164,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":110751875,"gmtCreate":1622505811497,"gmtModify":1704185163749,"author":{"id":"3578570760040163","authorId":"3578570760040163","name":"hmmwvms","avatar":"https://static.tigerbbs.com/a906b2444a1aca7cd161a6e1ee03687e","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3578570760040163","idStr":"3578570760040163"},"htmlText":"L&amp;C (like and comment) please. Thank you :)&nbsp;","listText":"L&amp;C (like and comment) please. Thank you :)&nbsp;","text":"L&C (like and comment) please. Thank you :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/110751875","repostId":1104481164,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4522662,"gmtCreate":1622507295120,"gmtModify":1680792268228,"authorId":3582015516749888,"author":{"id":3582015516749888,"idStr":"3582015516749888","authorId":3582015516749888,"name":"HH浩","avatar":"https://static.tigerbbs.com/2639351c97027c6f71c4d9729ef216d8","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":110751875,"type":1,"supId":0,"prevId":0,"content":"Reciprocate","text":"Reciprocate","html":"Reciprocate"},{"id":4522885,"gmtCreate":1622507867744,"gmtModify":1680792264788,"authorId":3578570760040163,"author":{"id":3578570760040163,"idStr":"3578570760040163","authorId":3578570760040163,"name":"hmmwvms","avatar":"https://static.tigerbbs.com/a906b2444a1aca7cd161a6e1ee03687e","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":110751875,"type":1,"supId":4522662,"prevId":0,"content":"Thank <u>you</u>","text":"Thank <u>you</u>","html":"Thank <u>you</u>"}],"langContent":"EN"},{"id":110762267,"gmtCreate":1622504977259,"gmtModify":1704185139753,"author":{"id":"3562498882012320","authorId":"3562498882012320","name":"Fartyclown","avatar":"https://static.tigerbbs.com/98da8c7130a89aa96f8dfc0e63f22fd3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3562498882012320","idStr":"3562498882012320"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/110762267","repostId":1104481164,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4538685,"gmtCreate":1622596472663,"gmtModify":1680792543376,"authorId":3562498882012320,"author":{"id":3562498882012320,"idStr":"3562498882012320","authorId":3562498882012320,"name":"Fartyclown","avatar":"https://static.tigerbbs.com/98da8c7130a89aa96f8dfc0e63f22fd3","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.30%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":110762267,"type":1,"supId":0,"prevId":0,"content":".","text":".","html":"."},{"id":4530215,"gmtCreate":1622546629683,"gmtModify":1680792402473,"authorId":3562498882012320,"author":{"id":3562498882012320,"idStr":"3562498882012320","authorId":3562498882012320,"name":"Fartyclown","avatar":"https://static.tigerbbs.com/98da8c7130a89aa96f8dfc0e63f22fd3","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.30%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":110762267,"type":1,"supId":4529845,"prevId":0,"content":"??","text":"??","html":"??"},{"id":4529845,"gmtCreate":1622544263466,"gmtModify":1680792393222,"authorId":3566789787456860,"author":{"id":3566789787456860,"idStr":"3566789787456860","authorId":3566789787456860,"name":"Godskitchen","avatar":"https://static.tigerbbs.com/8e19dd36ba7c4a40f3b317fb4ef84d16","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":110762267,"type":1,"supId":0,"prevId":0,"content":"<u>skill</u>","text":"<u>skill</u>","html":"<u>skill</u>"}],"langContent":"EN"},{"id":110475003,"gmtCreate":1622501918902,"gmtModify":1704185059671,"author":{"id":"3578697890023823","authorId":"3578697890023823","name":"ryanlow","avatar":"https://static.tigerbbs.com/ef1ede5b3203c87007bdaeb19d8327f4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3578697890023823","idStr":"3578697890023823"},"htmlText":"wow","listText":"wow","text":"wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/110475003","repostId":1104481164,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4521988,"gmtCreate":1622505005888,"gmtModify":1680792261453,"authorId":3576501151089163,"author":{"id":3576501151089163,"idStr":"3576501151089163","authorId":3576501151089163,"name":"aesemera","avatar":"https://static.tigerbbs.com/cdbbdd997dc9db0d9509166c15432fc2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":110475003,"type":1,"supId":4521127,"prevId":0,"content":"cheers!","text":"cheers!","html":"cheers!"},{"id":4521127,"gmtCreate":1622502118286,"gmtModify":1680792236843,"authorId":3575958434174944,"author":{"id":3575958434174944,"idStr":"3575958434174944","authorId":3575958434174944,"name":"Shadotaiger","avatar":"https://static.tigerbbs.com/c26a9d060fabab1c1347edbfc7329574","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":110475003,"type":1,"supId":0,"prevId":0,"content":"reply?","text":"reply?","html":"reply?"}],"langContent":"EN"},{"id":110452421,"gmtCreate":1622500236463,"gmtModify":1704185032440,"author":{"id":"3581996355402655","authorId":"3581996355402655","name":"LiuQY","avatar":"https://static.tigerbbs.com/675aff70b593df96675c1c39cf1bbae0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581996355402655","idStr":"3581996355402655"},"htmlText":"Gooooooooo","listText":"Gooooooooo","text":"Gooooooooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/110452421","repostId":1104481164,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4521887,"gmtCreate":1622504678280,"gmtModify":1680792252411,"authorId":3575125836760247,"author":{"id":3575125836760247,"idStr":"3575125836760247","authorId":3575125836760247,"name":"Singman","avatar":"https://static.tigerbbs.com/d770feb757705f2d631d2d5f381ae07b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":110452421,"type":1,"supId":0,"prevId":0,"content":"pls like and comment on me too.","text":"pls like and comment on me too.","html":"pls like and comment on me too."},{"id":4521092,"gmtCreate":1622501933579,"gmtModify":1680792238339,"authorId":3578697890023823,"author":{"id":3578697890023823,"idStr":"3578697890023823","authorId":3578697890023823,"name":"ryanlow","avatar":"https://static.tigerbbs.com/ef1ede5b3203c87007bdaeb19d8327f4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":110452421,"type":1,"supId":0,"prevId":0,"content":"wow","text":"wow","html":"wow"}],"langContent":"EN"},{"id":110451824,"gmtCreate":1622499926068,"gmtModify":1704185027751,"author":{"id":"3571129545109571","authorId":"3571129545109571","name":"MrMrsBean","avatar":"https://static.tigerbbs.com/8f1ab99fec06884945521404915aec0e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3571129545109571","idStr":"3571129545109571"},"htmlText":"[強]&nbsp;","listText":"[強]&nbsp;","text":"[強]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/110451824","repostId":1104481164,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4521069,"gmtCreate":1622501826540,"gmtModify":1680792238056,"authorId":3582053708073909,"author":{"id":3582053708073909,"idStr":"3582053708073909","authorId":3582053708073909,"name":"WeiChyi","avatar":"https://static.tigerbbs.com/1215c6c4b4962560ae3ef6fe8d752a11","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":110451824,"type":1,"supId":0,"prevId":0,"content":"K","text":"K","html":"K"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":147,"commentSize":36,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104481164"}